Use
Cases

IHSI’s horizon scanning system ensures that governments, HTA bodies, and policymakers have access to transparent, high-quality pharmaceutical intelligence. By offering insights into price trends, HTA workflows, healthcare system impacts, and strategic policymaking, IHSI reduces information asymmetry, enabling better decision-making in an evolving healthcare landscape.

Primary Use Cases

Supporting Price Negotiations and Procurement Decisions

HSI’s database provides a structured overview of the pharmaceutical landscape, allowing national health agencies to analyze and compare expected price requests and market trends. The intelligence supports:

  • Identifying pricing trends across various therapeutic areas.
  • Benchmarking industry expectations against historical data and similar products.
  • Strengthening negotiating power by giving governments access to independent, pre-market intelligence before pricing discussions begin.

By equipping payers with transparent and validated data, IHSI enables informed procurement decisions and more effective pricing negotiatio

Enhancing HTA Planning and Prioritization

Health Technology Assessment (HTA) agencies require early visibility into the pharmaceutical pipeline to prioritize evaluations and allocate resources effectively. The IHSI database supports:

  • Advanced prioritization of key pharmaceuticals based on regulatory timelines and anticipated approvals.
  • Efficient HTA workflow management, ensuring assessments align with market entry timelines.
  • Independent decision-making, reducing reliance on industry-driven insights.

By providing early-stage intelligence, IHSI enhances the efficiency of national HTA processes, ensuring timely evaluation of new therapies

Informing Healthcare System Preparedness

Governments and healthcare providers must prepare for high-impact pharmaceuticals that could reshape clinical, financial, and operational structures. The IHSI database allows:

  • Anticipation of disruptive therapies, enabling adjustments in treatment pathways and workforce planning.
  • Budget forecasting, offering insights into cost implications of emerging treatments.
  • Infrastructure adjustments, ensuring that new pharmaceutical technologies are effectively integrated into national healthcare systems.

By providing timely intelligence on upcoming therapies, IHSI helps healthcare planners mitigate risks and allocate resources proactive

Driving Policy and Strategic Decision-Making

Policymakers use IHSI’s intelligence to identify therapeutic areas with limited innovation and to determine whether policy intervention is required. The database:

  • Highlights gaps in clinical development, identifying areas where unmet medical needs persist.
  • Supports national healthcare strategies, offering evidence-based insights for investment planning.
  • Enhances regulatory preparedness, ensuring that governments can anticipate and react effectively to pharmaceutical trends.

By providing trusted, independent intelligence, IHSI empowers governments to make informed, long-term healthcare decisions that align with national health

Write to us:

Contact Form for white background